insulin glargine (Q21545): Difference between revisions
Jump to navigation
Jump to search
Created claim: medical condition treated (P663): hyperglycemia (Q18622) |
Created claim: medical condition treated (P663): type-1 diabetes (Q20819) |
||||||||||||||
| Property / medical condition treated | |||||||||||||||
| Property / medical condition treated: type-1 diabetes / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / medical condition treated: type-1 diabetes / qualifier | |||||||||||||||
start time: 19 April 2000
| |||||||||||||||
Revision as of 09:01, 20 March 2024
pharmaceutical drug
- HOE-901
- HOE-71GT
- Insulin Glargine (rDNA origin)
- Abasria
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | insulin glargine |
pharmaceutical drug |
|
Statements
C₂₆₇H₄₀₄N₇₂O₇₈S₆
0 references